Top Markets
#1 Black Phoenix Black Phoenix +21,376.82%
#2 Nesa Nesa +739.84%
#3 ADO Protocol ADO Protocol +101.31%
#4 Cortex Cortex +93.15%
#5 Ontology Gas Ontology Gas +78.86%
#6 Kinesis Silver Kinesis Silver +52.87%
#7 OpenEden OpenEden +40.75%
#8 Magma Finance Magma Finance +33.31%
#9 QuantixAI QuantixAI +23.21%
#10 EXOD EXOD +22.78%
Coin of the day
Black Phoenix Black Phoenix
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Orient Pharma Co., Ltd. Orient Pharma Co., Ltd.

Orient Pharma Co., Ltd.

4166
Classifica tra le azioni #18706
Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global... Orient Pharma Co., Ltd., established in Taipei, Taiwan, in 2008, is a global pharmaceutical company engaged in the research, development, production, and sales of medicinal products. Its extensive pipeline addresses diverse therapeutic areas, including psychiatric disorders such as anti-psychotics and psychostimulants, neurological conditions like Parkinson's and Alzheimer's diseases, and treatments for sialorrhea, tuberculosis, and attention deficit hyperactivity disorder (ADHD). Beyond its drug portfolio, the company is also at the forefront of developing advanced drug delivery technologies, featuring multi-stage controlled release systems, transdermal patches, orally disintegrating tablets, sustained-release formulations, and microgranule technology.
Prezzo delle azioni
$0.77907619
Capitalizzazione di mercato
$189.34M
Variazione (1 giorno)
0.41%
Variazione (1 anno)
-7.35%
Paese
TW
Scambia Orient Pharma Co., Ltd. (4166)

Categoria

Healthcare
Rapporto P/B per Orient Pharma Co., Ltd. (4166)
Rapporto P/B al 2026 TTM: 0
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Orient Pharma Co., Ltd., il rapporto P/B attuale (TTM) è 0. Alla fine del 2026, era pari a 0.
Storico del rapporto P/B per Orient Pharma Co., Ltd. da 2026 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
Non abbastanza dati per le date fornite.
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 2.4038 -
HK